Close
4

Quotient Sciences Quotient Sciences

X

Company profile for TWi Pharmaceuticals, Inc.

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs primarily for United States. Unlike the common generic drugs, developing high barrier generic drugs require a full array of expertise, including advanced scientific research, process development, patent analysis, regulatory compliances, and market and competitio...
TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs primarily for United States. Unlike the common generic drugs, developing high barrier generic drugs require a full array of expertise, including advanced scientific research, process development, patent analysis, regulatory compliances, and market and competition analysis. TWi focuses on the development of the following two categories of high barrier generic drugs: Paragraph IV: For generic drugs, Abbreviated New Drug Applications (ANDAs) are filed with US FDA for approval. These ANDAs are categorized into 4 categories - Paragraph I, II, III and IV. TWi's specialty is in the application of Paragraph IV (PIV) drugs which require strong science and technical know-how . Using our expertise in designing innovative alternative formulation, TWi is able to challenge or bypass the brand manufacturer's patent protection and to provide patients with drugs which have the same efficacy and quality as the branded drugs at a lower cost prior to the brand drugs' patent expiration. Generics with High Technical Barriers: For some drugs, although the patent protection for those drugs has already well expired, these drugs are still oligopolized by the original brand company and/or a limited number of generic companies due to high technical or other entry barriers. This type of drugs is also the key development focus for TWi. TWi Biotechnology, Inc. is a 100% fully-owned subsidiary of TWi Pharmaceuticals, Inc., focusing on the new drug research and development. Using innovation, quality, and efficiency as its core competency, TWi Biotechnology is dedicated on the development of treatment for innate inflammatory related diseases in metabolic, ophthalmology, and dermatology areas. Coupling with TWi's expertise and experience in formulation development, toxicology study, drug delivery system, clinical trial design, regulatory approval, TWi Biotechnology is poised to become the leader in developing treatment for above mentioned therapeutic areas.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
TWi Pharmaceuticals, Inc.
China Flag
Country
Country
China
Address
Address
4F, No. 41, Lane 221, Kang Chien Rd., Nei Hu Dist. Taipei 114, Taiwan
Telephone
Telephone
886-2-2657-3350
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY